A detailed history of First Fiduciary Investment Counsel, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, First Fiduciary Investment Counsel, Inc. holds 92,814 shares of JNJ stock, worth $13.5 Million. This represents 3.01% of its overall portfolio holdings.

Number of Shares
92,814
Previous 93,137 0.35%
Holding current value
$13.5 Million
Previous $13.6 Million 10.49%
% of portfolio
3.01%
Previous 2.95%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$145.48 - $167.38 $46,990 - $54,063
-323 Reduced 0.35%
92,814 $15 Million
Q2 2024

Aug 07, 2024

SELL
$144.38 - $157.78 $111,750 - $122,121
-774 Reduced 0.82%
93,137 $13.6 Million
Q1 2024

Apr 24, 2024

SELL
$155.22 - $162.74 $365,853 - $383,578
-2,357 Reduced 2.45%
93,911 $14.9 Million
Q4 2023

Feb 02, 2024

BUY
$145.6 - $158.88 $427,627 - $466,630
2,937 Added 3.15%
96,268 $15.1 Million
Q3 2023

Nov 07, 2023

SELL
$155.75 - $174.48 $180,825 - $202,571
-1,161 Reduced 1.23%
93,331 $14.5 Million
Q2 2023

Jul 21, 2023

BUY
$154.35 - $166.11 $124,714 - $134,216
808 Added 0.86%
94,492 $15.6 Million
Q1 2023

May 04, 2023

SELL
$151.05 - $180.26 $292,583 - $349,163
-1,937 Reduced 2.03%
93,684 $14.5 Million
Q4 2022

Feb 07, 2023

SELL
$160.2 - $179.79 $473,871 - $531,818
-2,958 Reduced 3.0%
95,621 $16.9 Million
Q3 2022

Oct 31, 2022

SELL
$161.33 - $179.52 $228,281 - $254,020
-1,415 Reduced 1.42%
98,579 $16.1 Million
Q2 2022

Jul 19, 2022

SELL
$168.19 - $186.01 $449,067 - $496,646
-2,670 Reduced 2.6%
99,994 $17.8 Million
Q1 2022

Apr 21, 2022

SELL
$158.14 - $179.59 $233,414 - $265,074
-1,476 Reduced 1.42%
102,664 $18.2 Million
Q4 2021

Jan 14, 2022

BUY
$155.93 - $173.01 $112,425 - $124,740
721 Added 0.7%
104,140 $17.8 Million
Q3 2021

Oct 07, 2021

SELL
$161.5 - $179.47 $537,956 - $597,814
-3,331 Reduced 3.12%
103,419 $16.7 Million
Q2 2021

Jul 29, 2021

SELL
$159.48 - $171.07 $431,712 - $463,086
-2,707 Reduced 2.47%
106,750 $17.6 Million
Q1 2021

May 12, 2021

SELL
$153.07 - $170.48 $2.17 Million - $2.42 Million
-14,209 Reduced 11.49%
109,457 $18 Million
Q4 2020

Feb 12, 2021

SELL
$137.11 - $157.38 $96,799 - $111,110
-706 Reduced 0.57%
123,666 $19.5 Million
Q3 2020

Nov 18, 2020

BUY
$140.38 - $153.83 $78,612 - $86,144
560 Added 0.45%
124,372 $18.5 Million
Q2 2020

Aug 10, 2020

BUY
$128.81 - $155.51 $89,909 - $108,545
698 Added 0.57%
123,812 $17.4 Million
Q1 2020

May 12, 2020

SELL
$111.14 - $153.99 $187,826 - $260,243
-1,690 Reduced 1.35%
123,114 $16.1 Million
Q4 2019

Feb 12, 2020

BUY
$127.5 - $146.44 $85,425 - $98,114
670 Added 0.54%
124,804 $18.2 Million
Q3 2019

Nov 15, 2019

BUY
$126.95 - $142.14 $265,071 - $296,788
2,088 Added 1.71%
124,134 $16.1 Million
Q2 2019

Jul 25, 2019

SELL
$131.15 - $144.24 $2.61 Million - $2.87 Million
-19,932 Reduced 14.04%
122,046 $17 Million
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $311,659 - $346,539
-2,479 Reduced 1.72%
141,978 $19.8 Million
Q4 2018

Feb 04, 2019

BUY
$122.84 - $147.84 $89,059 - $107,184
725 Added 0.5%
144,457 $18.6 Million
Q3 2018

Oct 29, 2018

BUY
$121.58 - $142.88 $414,223 - $486,792
3,407 Added 2.43%
143,732 $19.9 Million
Q2 2018

Aug 15, 2018

BUY
$119.4 - $131.76 $504,465 - $556,686
4,225 Added 3.1%
140,325 $17 Million
Q1 2018

May 03, 2018

BUY
$125.1 - $148.14 $61,549 - $72,884
492 Added 0.36%
136,100 $17.4 Million
Q4 2017

Feb 20, 2018

SELL
$131.22 - $143.62 $654,131 - $715,945
-4,985 Reduced 3.55%
135,608 $18.9 Million
Q3 2017

Nov 20, 2017

BUY
$129.47 - $135.38 $46,220 - $48,330
357 Added 0.25%
140,593 $18.3 Million
Q2 2017

Aug 15, 2017

BUY
N/A
140,236
140,236 $18.6 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track First Fiduciary Investment Counsel, Inc. Portfolio

Follow First Fiduciary Investment Counsel, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Fiduciary Investment Counsel, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Fiduciary Investment Counsel, Inc. with notifications on news.